Detalhe da pesquisa
1.
Asian participants' experience in phase 3/3b studies of long-acting cabotegravir and rilpivirine: Efficacy, safety, pharmacokinetic, and virological outcomes through week 96.
HIV Med
; 25(3): 381-390, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38147871
2.
Efficacy, safety, and pharmacokinetics by BMI category in Phase 3/3b cabotegravir + rilpivirine long-acting trials.
J Infect Dis
; 2023 Dec 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38134313
3.
Expanded Multivariable Models to Assist Patient Selection for Long-Acting Cabotegravir + Rilpivirine Treatment: Clinical Utility of a Combination of Patient, Drug Concentration, and Viral Factors Associated With Virologic Failure.
Clin Infect Dis
; 77(10): 1423-1431, 2023 11 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-37340869
4.
Pregnancy outcomes and pharmacokinetics in pregnant women living with HIV exposed to long-acting cabotegravir and rilpivirine in clinical trials.
HIV Med
; 24(5): 568-579, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36411596
5.
Predicting Volume of Distribution in Humans: Performance of In Silico Methods for a Large Set of Structurally Diverse Clinical Compounds.
Drug Metab Dispos
; 49(2): 169-178, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33239335
6.
Mechanistic Basis of Cabotegravir-Glucuronide Disposition in Humans.
J Pharmacol Exp Ther
; 370(2): 269-277, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31175220
7.
Hepatobiliary Disposition of Atovaquone: A Case of Mechanistically Unusual Biliary Clearance.
J Pharmacol Exp Ther
; 366(1): 37-45, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29653960
8.
New Frontiers: Approaches to Understand the Mechanistic Basis of Renal Toxicity.
Toxicol Pathol
; 46(8): 1002-1005, 2018 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30189777
9.
Drug interaction profile of the HIV integrase inhibitor cabotegravir: assessment from in vitro studies and a clinical investigation with midazolam.
Xenobiotica
; 46(5): 445-56, 2016.
Artigo
em Inglês
| MEDLINE | ID: mdl-26340566
10.
Breast cancer resistance protein (ABCG2) in clinical pharmacokinetics and drug interactions: practical recommendations for clinical victim and perpetrator drug-drug interaction study design.
Drug Metab Dispos
; 43(4): 490-509, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25587128
11.
Understanding the transport properties of metabolites: case studies and considerations for drug development.
Drug Metab Dispos
; 42(4): 650-64, 2014 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-24346835
12.
In vitro investigations into the roles of drug transporters and metabolizing enzymes in the disposition and drug interactions of dolutegravir, a HIV integrase inhibitor.
Drug Metab Dispos
; 41(2): 353-61, 2013 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-23132334
13.
Central nervous system disposition and metabolism of Fosdevirine (GSK2248761), a non-nucleoside reverse transcriptase inhibitor: an LC-MS and Matrix-assisted laser desorption/ionization imaging MS investigation into central nervous system toxicity.
Chem Res Toxicol
; 26(2): 241-51, 2013 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-23227887
14.
Evaluation of drug interactions of GSK1292263 (a GPR119 agonist) with statins: from in vitro data to clinical study design.
Xenobiotica
; 43(6): 498-508, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23256625
15.
The Journey to AAPS 2020: a Reflection from Strategic Planning to PharmSci 360.
AAPS PharmSciTech
; 19(8): 3325-3327, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30390237
16.
Practical dosing guidance for the management of clinician-administered injections of long-acting cabotegravir and rilpivirine.
Ther Adv Infect Dis
; 10: 20499361231214626, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38107552
17.
Assessment of the drug interaction risk for remogliflozin etabonate, a sodium-dependent glucose cotransporter-2 inhibitor: evidence from in vitro, human mass balance, and ketoconazole interaction studies.
Drug Metab Dispos
; 40(11): 2090-101, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-22851617
18.
Lapatinib distribution in HER2 overexpressing experimental brain metastases of breast cancer.
Pharm Res
; 29(3): 770-81, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22011930
19.
Clinical Relevance of Hepatic and Renal P-gp/BCRP Inhibition of Drugs: An International Transporter Consortium Perspective.
Clin Pharmacol Ther
; 112(3): 573-592, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35612761
20.
Exploring predictors of HIV-1 virologic failure to long-acting cabotegravir and rilpivirine: a multivariable analysis.
AIDS
; 35(9): 1333-1342, 2021 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33730748